TREPROSTINIL OrPha sol perf 2.5 mg/ml 10 ml
7680673570029
CH-67357
B01AC21
02.07.1.
Reimbursement limitations:
REMODULIN
Traitement à long terme de l'hypertension pulmonaire et de l'hypertension artérielle pulmonaire, associée à une …
1 / 3
google
Details
- Product number
- 6735702
- CPT
- -
- Packaging group
- 1 x 10 ml
- Unit
- Durchstechflasche(n)
- Composition
- treprostinilum 2.5 mg ut treprostinilum natricum, natrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum, natrii hydroxidum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.73 mg.
Articles (1)
Treprostinil OrPha 2.5 mg/ml, Infusionslösung
Infusionslösung
1 x 10 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.73 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2436.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2020
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 67357
- Drug name
- Treprostinil OrPha, Infusionslösung
- Galenic form
- LSPA
- ATC Code
- B01AC21
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/06/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TREPROSTINIL OrPha sol perf 2.5 mg/ml 10 ml
- Description (DE)
- TREPROSTINIL OrPha Inf Lös 2.5 mg/ml 10 ml
- Market launch
- 09/06/2020
- Narcotic (BTM)
- No